Nuclear Medicine/ Radiopharmaceuticals Market Trend, Segmentation, Opportunities and Forecast To 2018
Latest Report Available at Analytical Research Cognizance Nuclear Medicine/ Radiopharmaceuticals Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
Browse the full report @ http://www.arcognizance.com/report/global-nuclear-medicine-radiopharmaceuticals-market-by-manufacturers-regions-type-and-application-forecast-to-2023
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
Scope of the Report:
This report focuses on the Nuclear Medicine/Radiopharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.
In application, nuclear medicine / radiopharmaceuticals is for treatment oncology, thyroid, cardiology and other dieses. The nuclear medicine / radiopharmaceuticals market is mainly driven by growing demand for treatment cardiology which accounts for nearly 42.19 % of total downstream consumption of Nuclear Medicine / Radiopharmaceuticals in China.
The worldwide market for Nuclear Medicine/Radiopharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Request a sample of this report @ http://www.arcognizance.com/enquiry-sample/67390
Market Segment by Manufacturers, this report covers
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diagnostic
Therapeutic
Market Segment by Applications, can be divided into
Oncology
Thyroid
Cardiology
There are 15 Chapters to deeply display the global Nuclear Medicine/Radiopharmaceuticals market.
Chapter 1, to describe Nuclear Medicine/Radiopharmaceuticals Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Nuclear Medicine/Radiopharmaceuticals, with sales, revenue, and price of Nuclear Medicine/Radiopharmaceuticals, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Nuclear Medicine/Radiopharmaceuticals, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Nuclear Medicine/Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Nuclear Medicine/Radiopharmaceuticals sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Purchase copy of this Report @ http://www.arcognizance.com/purchase/67390
Some Points from Toc:
Chapter One: Market Overview
1.1 Nuclear Medicine/Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Diagnostic
1.2.2 Therapeutic
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Thyroid
1.3.3 Cardiology
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
Chapter Two: Manufacturers Profiles
2.1 China Isotope & Radiation
2.1.1 Business Overview
2.1.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Dongcheng
2.2.1 Business Overview
2.2.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Jaco
2.3.1 Business Overview
2.3.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Ciaeriar
2.4.1 Business Overview
2.4.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Advanced Molecular-imaging Solution
2.5.1 Business Overview
2.5.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Shanghai Atom Kexing
2.6.1 Business Overview
2.6.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
About US:
www.arcognizance.com is an initiation in this new era of “analysis @ thought.” We are on a mission to replace the conventional research programs and give way to the latest methods and information for the organizations. We have created this hub of analytical research papers where you can get an access to the latest and the best research papers coming out from some reliable and budding research houses. After the advent of “new analytics" based on the data collection facilities of big data, the face of "business research facilities" has changed drastically. With ARC our experts have created a bookshelf where you can check out the research reports that are an outcome of the progression of knowledge in various industry sectors. Alongside you can also check some research papers, market reports, and forecasts that are talking about the "out of the box" developments in the market.
Contact US:
Name: Analytical research cognizance
Address: 100 Church Street,
8th floor, Manhattan,
New York 10007
Phone: +1 (646) 434-7969 +91 90967 44448
Email: [email protected]